Click for best price
Antispasmodic Drugs Market Size, Share 2022
Antispasmodic drugs such as dicyclomine (Bentyl) and hyoscyamine (Levsin) relieve the stomach cramps brought on by IBS by relaxing the smooth muscle of the gut. They also may cause constipation, so they aren't usually prescribed for people who suffer from IBS-C. Other side effects are dry mouth, drowsiness, and blurred vision.
This report contains market size and forecasts of Anti-spasmodic Drugs in Global, including the following market information:
Global Anti-spasmodic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-spasmodic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antimuscarinics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-spasmodic Drugs include Pfizer, Allergan, Ipsen, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical Industries and Merz Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-spasmodic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-spasmodic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-spasmodic Drugs Market Segment Percentages, by Type, 2021 (%)
Antimuscarinics
Smooth Muscle Relaxants
Global Anti-spasmodic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-spasmodic Drugs Market Segment Percentages, by Application, 2021 (%)
Offline Channel
Online Channel
Global Anti-spasmodic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-spasmodic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-spasmodic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-spasmodic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Allergan
Ipsen
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Daewoong Pharmaceutical
Acorda Therapeutics
SteriMax
Emcure Pharmaceuticals
Sawai Pharmaceutical
Orient Pharma
| Report Attributes |
Report Details |
| Report Title |
Anti-spasmodic Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-spasmodic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-spasmodic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-spasmodic Drugs Overall Market Size
2.1 Global Anti-spasmodic Drugs Market Size: 2021 VS 2028
2.2 Global Anti-spasmodic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-spasmodic Drugs Players in Global Market
3.2 Top Global Anti-spasmodic Drugs Companies Ranked by Revenue
3.3 Global Anti-spasmodic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-spasmodic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-spasmodic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-spasmodic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-spasmodic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-spasmodic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anti-spasmodic Drugs Market Size Markets, 2021 & 2028
4.1.2 Antimuscarinics
4.1.3 Smooth Muscle Relaxants
4.2 By Type - Global Anti-spasmodic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-spasmodic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Anti-spasmodic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-spasmodic Drugs Market Size, 2021 & 2028
5.1.2 Offline Channel
5.1.3 Online Channel
5.2 By Application - Global Anti-spasmodic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-spasmodic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Anti-spasmodic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Anti-spasmodic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-spasmodic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-spasmodic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Anti-spasmodic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Anti-spasmodic Drugs Revenue, 2017-2028
6.3.2 US Anti-spasmodic Drugs Market Size, 2017-2028
6.3.3 Canada Anti-spasmodic Drugs Market Size, 2017-2028
6.3.4 Mexico Anti-spasmodic Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Anti-spasmodic Drugs Revenue, 2017-2028
6.4.2 Germany Anti-spasmodic Drugs Market Size, 2017-2028
6.4.3 France Anti-spasmodic Drugs Market Size, 2017-2028
6.4.4 U.K. Anti-spasmodic Drugs Market Size, 2017-2028
6.4.5 Italy Anti-spasmodic Drugs Market Size, 2017-2028
6.4.6 Russia Anti-spasmodic Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Anti-spasmodic Drugs Market Size, 2017-2028
6.4.8 Benelux Anti-spasmodic Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Anti-spasmodic Drugs Revenue, 2017-2028
6.5.2 China Anti-spasmodic Drugs Market Size, 2017-2028
6.5.3 Japan Anti-spasmodic Drugs Market Size, 2017-2028
6.5.4 South Korea Anti-spasmodic Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Anti-spasmodic Drugs Market Size, 2017-2028
6.5.6 India Anti-spasmodic Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Anti-spasmodic Drugs Revenue, 2017-2028
6.6.2 Brazil Anti-spasmodic Drugs Market Size, 2017-2028
6.6.3 Argentina Anti-spasmodic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-spasmodic Drugs Revenue, 2017-2028
6.7.2 Turkey Anti-spasmodic Drugs Market Size, 2017-2028
6.7.3 Israel Anti-spasmodic Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Anti-spasmodic Drugs Market Size, 2017-2028
6.7.5 UAE Anti-spasmodic Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Anti-spasmodic Drugs Major Product Offerings
7.1.4 Pfizer Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Anti-spasmodic Drugs Major Product Offerings
7.2.4 Allergan Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.2.5 Allergan Key News
7.3 Ipsen
7.3.1 Ipsen Corporate Summary
7.3.2 Ipsen Business Overview
7.3.3 Ipsen Anti-spasmodic Drugs Major Product Offerings
7.3.4 Ipsen Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.3.5 Ipsen Key News
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Corporate Summary
7.4.2 Teva Pharmaceuticals Business Overview
7.4.3 Teva Pharmaceuticals Anti-spasmodic Drugs Major Product Offerings
7.4.4 Teva Pharmaceuticals Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.4.5 Teva Pharmaceuticals Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Anti-spasmodic Drugs Major Product Offerings
7.5.4 Novartis Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Anti-spasmodic Drugs Major Product Offerings
7.6.4 Johnson & Johnson Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Corporate Summary
7.7.2 Takeda Pharmaceutical Business Overview
7.7.3 Takeda Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.7.4 Takeda Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.7.5 Takeda Pharmaceutical Key News
7.8 Sun Pharmaceutical Industries
7.8.1 Sun Pharmaceutical Industries Corporate Summary
7.8.2 Sun Pharmaceutical Industries Business Overview
7.8.3 Sun Pharmaceutical Industries Anti-spasmodic Drugs Major Product Offerings
7.8.4 Sun Pharmaceutical Industries Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.8.5 Sun Pharmaceutical Industries Key News
7.9 Merz Pharma
7.9.1 Merz Pharma Corporate Summary
7.9.2 Merz Pharma Business Overview
7.9.3 Merz Pharma Anti-spasmodic Drugs Major Product Offerings
7.9.4 Merz Pharma Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.9.5 Merz Pharma Key News
7.10 Mylan
7.10.1 Mylan Corporate Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Anti-spasmodic Drugs Major Product Offerings
7.10.4 Mylan Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.10.5 Mylan Key News
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Corporate Summary
7.11.2 Fresenius Kabi Business Overview
7.11.3 Fresenius Kabi Anti-spasmodic Drugs Major Product Offerings
7.11.4 Fresenius Kabi Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.11.5 Fresenius Kabi Key News
7.12 Endo International
7.12.1 Endo International Corporate Summary
7.12.2 Endo International Business Overview
7.12.3 Endo International Anti-spasmodic Drugs Major Product Offerings
7.12.4 Endo International Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.12.5 Endo International Key News
7.13 Daewoong Pharmaceutical
7.13.1 Daewoong Pharmaceutical Corporate Summary
7.13.2 Daewoong Pharmaceutical Business Overview
7.13.3 Daewoong Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.13.4 Daewoong Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.13.5 Daewoong Pharmaceutical Key News
7.14 Acorda Therapeutics
7.14.1 Acorda Therapeutics Corporate Summary
7.14.2 Acorda Therapeutics Business Overview
7.14.3 Acorda Therapeutics Anti-spasmodic Drugs Major Product Offerings
7.14.4 Acorda Therapeutics Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.14.5 Acorda Therapeutics Key News
7.15 SteriMax
7.15.1 SteriMax Corporate Summary
7.15.2 SteriMax Business Overview
7.15.3 SteriMax Anti-spasmodic Drugs Major Product Offerings
7.15.4 SteriMax Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.15.5 SteriMax Key News
7.16 Emcure Pharmaceuticals
7.16.1 Emcure Pharmaceuticals Corporate Summary
7.16.2 Emcure Pharmaceuticals Business Overview
7.16.3 Emcure Pharmaceuticals Anti-spasmodic Drugs Major Product Offerings
7.16.4 Emcure Pharmaceuticals Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.16.5 Emcure Pharmaceuticals Key News
7.17 Sawai Pharmaceutical
7.17.1 Sawai Pharmaceutical Corporate Summary
7.17.2 Sawai Pharmaceutical Business Overview
7.17.3 Sawai Pharmaceutical Anti-spasmodic Drugs Major Product Offerings
7.17.4 Sawai Pharmaceutical Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.17.5 Sawai Pharmaceutical Key News
7.18 Orient Pharma
7.18.1 Orient Pharma Corporate Summary
7.18.2 Orient Pharma Business Overview
7.18.3 Orient Pharma Anti-spasmodic Drugs Major Product Offerings
7.18.4 Orient Pharma Anti-spasmodic Drugs Revenue in Global Market (2017-2022)
7.18.5 Orient Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-spasmodic Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-spasmodic Drugs Market Drivers in Global Market
Table 3. Anti-spasmodic Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-spasmodic Drugs in Global Market
Table 5. Top Anti-spasmodic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-spasmodic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-spasmodic Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-spasmodic Drugs Product Type
Table 9. List of Global Tier 1 Anti-spasmodic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-spasmodic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-spasmodic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Anti-spasmodic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-spasmodic Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-spasmodic Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-spasmodic Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-spasmodic Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-spasmodic Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-spasmodic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-spasmodic Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Anti-spasmodic Drugs Product Offerings
Table 32. Pfizer Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Anti-spasmodic Drugs Product Offerings
Table 35. Allergan Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Ipsen Corporate Summary
Table 37. Ipsen Anti-spasmodic Drugs Product Offerings
Table 38. Ipsen Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Teva Pharmaceuticals Corporate Summary
Table 40. Teva Pharmaceuticals Anti-spasmodic Drugs Product Offerings
Table 41. Teva Pharmaceuticals Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Anti-spasmodic Drugs Product Offerings
Table 44. Novartis Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Anti-spasmodic Drugs Product Offerings
Table 47. Johnson & Johnson Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Takeda Pharmaceutical Corporate Summary
Table 49. Takeda Pharmaceutical Anti-spasmodic Drugs Product Offerings
Table 50. Takeda Pharmaceutical Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Sun Pharmaceutical Industries Corporate Summary
Table 52. Sun Pharmaceutical Industries Anti-spasmodic Drugs Product Offerings
Table 53. Sun Pharmaceutical Industries Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Merz Pharma Corporate Summary
Table 55. Merz Pharma Anti-spasmodic Drugs Product Offerings
Table 56. Merz Pharma Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Mylan Corporate Summary
Table 58. Mylan Anti-spasmodic Drugs Product Offerings
Table 59. Mylan Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Fresenius Kabi Corporate Summary
Table 61. Fresenius Kabi Anti-spasmodic Drugs Product Offerings
Table 62. Fresenius Kabi Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Endo International Corporate Summary
Table 64. Endo International Anti-spasmodic Drugs Product Offerings
Table 65. Endo International Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Daewoong Pharmaceutical Corporate Summary
Table 67. Daewoong Pharmaceutical Anti-spasmodic Drugs Product Offerings
Table 68. Daewoong Pharmaceutical Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Acorda Therapeutics Corporate Summary
Table 70. Acorda Therapeutics Anti-spasmodic Drugs Product Offerings
Table 71. Acorda Therapeutics Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 72. SteriMax Corporate Summary
Table 73. SteriMax Anti-spasmodic Drugs Product Offerings
Table 74. SteriMax Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Emcure Pharmaceuticals Corporate Summary
Table 76. Emcure Pharmaceuticals Anti-spasmodic Drugs Product Offerings
Table 77. Emcure Pharmaceuticals Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Sawai Pharmaceutical Corporate Summary
Table 79. Sawai Pharmaceutical Anti-spasmodic Drugs Product Offerings
Table 80. Sawai Pharmaceutical Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
Table 81. Orient Pharma Corporate Summary
Table 82. Orient Pharma Anti-spasmodic Drugs Product Offerings
Table 83. Orient Pharma Anti-spasmodic Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Anti-spasmodic Drugs Segment by Type in 2021
Figure 2. Anti-spasmodic Drugs Segment by Application in 2021
Figure 3. Global Anti-spasmodic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-spasmodic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-spasmodic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-spasmodic Drugs Revenue in 2021
Figure 8. By Type - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 12. US Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 24. China Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-spasmodic Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-spasmodic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ipsen Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Pharmaceuticals Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takeda Pharmaceutical Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sun Pharmaceutical Industries Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merz Pharma Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mylan Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fresenius Kabi Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Endo International Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Daewoong Pharmaceutical Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Acorda Therapeutics Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. SteriMax Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Emcure Pharmaceuticals Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Sawai Pharmaceutical Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Orient Pharma Anti-spasmodic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
